Novel Compounds for Preventing SARS-CoV-2 Viral Replication and Treating COVID-19
Description
Provided herein are novel compounds as SARS-CoV-2-related 3C-like protease inhibitors, pharmaceutical compositions, use of such compounds in preventing SARS-CoV-2 viral replication and treating COVID-19, and processes for preparing such compounds.
